ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹100 Cr | ₹92 Cr | ₹46 Cr | ₹-1.95 Cr | ₹-117 Cr |
What is the latest Consolidated Net Profit of ORCHID PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹-1.95 Cr |
| Mar2021 | ₹-117 Cr |
How is Consolidated Net Profit of ORCHID PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 8.13 | |
| Mar2024 | ₹92 Cr | 98.99 | |
| Mar2023 | ₹46 Cr | Positive | |
| Mar2022 | ₹-1.95 Cr | Negative | |
| Mar2021 | ₹-117 Cr | - | |
Compare Consolidated Net Profit of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,586.5 Cr | -9.6% | -25.1% | -46.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -9.6% |
-25.1% |
-46.4% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses